In our previous studies, we suggested that chrysophanol-based therapy could mitigate oral cancer progression through the activation of ferroptosis and modulate cell death, mTOR/peroxisome proliferator-activated receptor α (PPAR-α) signaling, and ROS accumulation in an iron-dependent manner [78,79]. The gene discussed is MTOR; the disease is lip and oral cavity carcinoma.